Antimicrobial Considerations in the Perioperative Patient

Veterinary Clinics of North America - Small Animal Practice

Volumn 45, Issue 3, 2015, Pages 585-608

  Boothe, Dawn Merton ^a   Boothe, Harry W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Antimicrobial prophylaxis; Antiseptics; Disinfectants; Surgical site infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFACLOR; CEFALOTIN; CEFAZOLIN; CEFODIZIME; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTIOFUR; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ENROFLOXACIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; RIFAMPICIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; ASEPSIS; BIOFILM; COLONY FORMING UNIT; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MUCOSA; NONHUMAN; PERIOPERATIVE PERIOD; PHARMACODYNAMICS; REVIEW; SKIN DECONTAMINATION; SURGICAL INFECTION; SURGICAL PATIENT; TISSUE PREPARATION; WOUND; ANIMAL; ANTIBIOTIC PROPHYLAXIS; CAT; CAT DISEASES; DOG; DOG DISEASES; MICROBIOLOGY; SURGICAL WOUND INFECTION; VETERINARY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CAT DISEASES; CATS; DOG DISEASES; DOGS; PERIOPERATIVE PERIOD; SURGICAL WOUND INFECTION;

EID: 84927174196     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2015.01.006     Document Type: Review

References (74)

1. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control 1999, 27:97-132.
2. Owens C.D., Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. JHosp Infect 2008, 70(Suppl 2):3-10.
3. Alexander J.W., Solomkin J.S., Edwards M.J. Updated recommendations for control of Surgical site infections. Ann Surg 2011, 253:1082-1093.
4. Turk R., Singh A., Weese J.S. Prospective surgical site infection surveillance in dogs. Vet Surg 2014, 44:2-8.
5. Singh A., Walker M., Rousseau J., et al. Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet Res 2013, 9:93.
6. Nazarali A., Singh A., Weese J.S. Perioperative administration of antimicrobials during tibial plateau leveling osteotomy. Vet Surg 2014, 43:966-971.
7. Schmiedt C.W., Holzman G., Schwarz T., et al. Survival, complications, and analysis of risk factors after renal transplantation in cats. Vet Surg 2008, 37:683-695.
8. Aly S.A., Debavalya N., Suh S.J., et al. Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration. Can J Microbiol 2012, 58:1288-1294.
9. Lawrence M., Kukanich K., Kukanich B., et al. Effect of cefovecin on the fecal flora of healthy dogs. Vet J 2013, 198:259-266.
10. Bratzler D.W., Dellinger E.P., Olsen K.M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013, 14:73-156.
11. Boothe D.M. Principles of Antimicrobial Therapy. Small Animal Clinical Pharmacology and Therapeutics 2012, 128-178. Elsevier, Philadelphia. 2nd edition. D.M. Boothe (Ed.).
12. Githaiga A., Ndirangu M., Paterson D.L. Infections in the immunocompromised patient. Textbook of critical care 2005, Saunders, Philadelphia. 5th edition. M.P. Fink, E. Abraham, E. Vincent (Eds.).
13. Eugster S., Schawalder P., Gaschen F., et al. Aprospective study of postoperative surgical site infections in dogs and cats. Vet Surg 2004, 33:542-550.
14. Thungrat K.T., Carpenter M., Boothe D.M. Antimicrobial susceptibility patterns of clinical Escherichia coli isolates from dogs and cats in the United States: January 2008 through January 2013. Vet Microbiol 2014.
15. Weese J.S., van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 2010, 140:418-429.
16. Hawn M.T., Richman J.S., Vick C.C., et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013, 148:649-657.
17. Stegemann M.R., Sherington J., Blanchflower S. Pharmacokinetics and pharmacodynamics of cefovecin in dogs. JVet Pharmacol Ther 2006, 29:501-511.
18. Daude-Lagrave A., Carozzo C., Fayolle P., et al. Infection rates in surgical procedures: a comparison of cefalexin vs. a placebo. Vet Comp Orthop Traumatol 2001, 14(3):146-150.
19. Hettlich B.F., Boothe H.W., Simpson R.B., et al. Effect of tympanic cavity evacuation and flushing on microbial isolates during total ear canal ablation with lateral bulla osteotomy in dogs. JAm Vet Med Assoc 2005, 227:748-755.
20. McHugh S.M., Collins C.J., Corrigan M.A., et al. The role of topical antibiotics used as prophylaxis in surgical site infection prevention. JAntimicrob Chemother 2011, 66:693-701.
21. Huiras P., Logan J.K., Papadopoulos S., et al. Local antimicrobial administration for prophylaxis of surgical site infections. Pharmacotherapy 2001, 32:1006-1019.
22. Atilla A., Boothe H.W., Tollett M., et al. Invitro elution of amikacin and vancomycin from impregnated plaster of Paris beads. Vet Surg 2010, 39:715-721.
23. Phillips H., Boothe D.M., Shofer F., et al. Invitro elution studies of amikacin and cefazolin from polymethylmethacrylate. Vet Surg 2007, 36:272-278.
24. Ham K., Griff D., Seddighi M., et al. Clinical application of tobramycin-impregnated calcium sulfate beads in six dogs (2002-2004). JAm Anim Hosp Assoc 2008, 44:320-326.
25. Sayegh A.I., Moore R.M. Polymethylmethacrylate beads for treating orthopedic infections. Compend Contin Educ Pract Vet 2003, 25:788-795.
26. Neut D., van de Belt H., Stokroos I., et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. JAntimicrob Chemother 2001, 47:885-891.
27. Owen M.R., Moores A.P., Cox R.J. Management of MRSA septic arthritis in a dog using a gentamicin-impregnated collagen sponge. JSmall Anim Pract 2004, 45:609-612.
28. Mealey K.L., Boothe D.M. Nephrotoxicosis associated with topical administration of gentamicin in a cat. JAm Vet Med Assoc 1994, 204:1919-1921.
29. Rossolini G.M., Arena F., Pecile P., et al. Update on the antibiotic resistance crisis. Curr Opin Pharmacol 2014, 18C:56-60.
30. Mouton J.W., Ambrose P.G., Canton R., et al. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat 2011, 14:107-117.
31. Martinez M.N., Papich M.G., Drusano G.L. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamics target. Antimicrob Agents Chemother 2012, 56:2795-2805.
32. Liu X., Boothe D.M., Jin Y., et al. Invitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States. World J Microbiol Biotechnol 2013, 29:347-354.
33. Ryan D.M. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. JAntimicrob Chemother 1993, 31(Suppl D):1-16.
34. Barza M. Tissue directed antibiotic therapy: antibiotic dynamics in cells and tissues. Clin Infect Dis 1994, 19:910-915.
35. Müller M., dela Peña A., Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother 2004, 48:1441-1453.
36. Bamberger D.M., Foxworth J.W., Bridewell D.L., et al. Extravascular antimicrobial distribution and the respective blood and urine concentrations in humans. Antibiotics in laboratory medicine 2005, 719-848. Williams & Wilkins, Baltimore (MD). V. Lorian (Ed.).
37. Boothe D.M., Boeckh A., Boothe H.W., et al. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration. Vet Ther 2001, 2:120-128.
38. Brunner M., Derendorf H., Müller M. Microdialysis for invivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs. Curr Opin Pharmacol 2005, 5:495-499.
39. Coutin J.V., Lanz O.I., Magnin-Bissel G.C., et al. Cefazolin concentration in surgically created wounds treated with negative pressure wound therapy compared to surgically created wounds treated with nonadherent wound dressings. Vet Surg 2015, 44:9-16.
40. Dahyot C., Marchand S., Pessini G.L., et al. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of Acinetobacter baumannii-infected rats. Antimicrob Agents Chemother 2006, 50:2265-2267.
41. Boothe D.M., Boeckh A., Boothe H.W. Evaluation of the distribution of enrofloxacin by circulating leukocytes to sites of inflammation in dogs. Am J Vet Res 2009, 70:16-22.
42. Clutterbuck A.L., Woods E.J., Knottenbelt D.C., et al. Biofilms and their relevance to veterinary medicine. Vet Microbiol 2007, 121:1-17.
43. Hentzer M., Eberl L., Nielsen J., et al. Quorum sensing: a novel target for the treatment of biofilm infections. BioDrugs 2003, 17:241-250.
44. Marsh P.D. Dental plaque: biological significance of a biofilm and community life-style. JClin Periodontol 2005, 32(Suppl 6):7-15.
45. Biofilms and veterinary medicine 2011, Springer, Heidelberg (Germany); Dordrecht (Netherlands); New York. S.L. Percival, D.C. Knottenbelt, C.A. Cochrane (Eds.).
46. Arciola C.R., Campoccia D., Speziale P., et al. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 2012, 33:5967-5982.
47. Bonkat G., Rieken M., Siegel F.P., et al. Microbial ureteral stent colonization in renal transplant recipients: frequency and influence on the short-time functional outcome. Transpl Infect Dis 2012, 14:57-63.
48. Turk R., Singh A., Rousseau J., et al. Invitro evaluation of DispersinB on methicillin-resistant Staphylococcus pseudintermedius biofilm. Vet Microbiol 2013, 166(3-4):576-579.
49. Crabtree T.D., Pelletier S.J., Pruett T.L. Surgical antisepsis. Disinfection, sterilization, and preservation 2001, 919. Lippincott Williams & Wilkins, Philadelphia. 5th edition. S.S. Block (Ed.).
50. Larson E.L. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995, 23:251-269.
51. Suchomel M., Gnant G., Weinlich M., et al. Surgical hand disinfection using alcohol: the effects of alcohol type, mode and duration of application. JHosp Infect 2009, 71:228-233.
52. Larson E.L., Aiello A.E., Heilman J.M., et al. Comparison of different regimens for surgical hand preparation. AORN J 2001, 73:412-420.
53. Shmon C. Assessment and preparation of the surgical patient and the operating team. Textbook of small animal surgery 2003, 162. Saunders, Philadelphia. 3rd edition. D. Slatter (Ed.).
54. Osuna D.J., DeYoung D.J., Walker R.L. Comparison of three skin preparation techniques in the dog. Part I: Experimental trial. Vet Surg 1990, 19:14-19.
55. Neihaus S.A., Hathcock T.L., Boothe D.M., et al. Presurgical antiseptic efficacy of chlorhexidine diacetate and providone-iodine in the canine preputial cavity. JAm Anim Hosp Assoc 2011, 47:406-412.
56. Kampf G., Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004, 17:863-893.
57. Rahn R. Review presentation on povidone-iodine antisepsis in the oral cavity. Postgrad Med J 1993, 69:S4-S9.
58. Denton G.W. Chlorhexidine. Disinfection, sterilization, and preservation 2001, 321. Lippincott Williams & Wilkins, Philadelphia. 5th edition. S.S. Block (Ed.).
59. Ashley K.C. The antimicrobial properties of two commonly used antiseptic mouthwashes-corsodyl and oraldene. JAppl Bacteriol 1984, 56:221-225.
60. Swaim S.F., Lee A.H. Topical wound medications: a review. JAm Vet Med Assoc 1987, 190:1588-1593.
61. Lozier S., Pope E., Berg J. Effects of four preparations of 0.05% chlorhexidine diacetate on wound healing in dogs. Vet Surg 1992, 21:107-112.
62. Lemarié R.J., Hosgood G. Antiseptics and disinfectants in small animal practice. Compend Contin Educ Pract Vet 1995, 17:1339-1351.
63. de La Peña A., Dalla Costa T., Talton J.D., et al. Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm Res 2001, 18:1310-1314.
64. de La Peña A., Brunner M., Eichler H.G., et al. Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans. JClin Pharmacol 2002, 42:403-411.
65. Joukhadar C., Klein N., Mayer B.X., et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002, 7:1478-1482.
66. Herkner H., Müller M.R., Kreischitz N., et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med 2002, 165:273-276.
67. Müller M., Rohde B., Kovar A., et al. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. JClin Pharmacol 1997, 37:1108-1113.
68. Shukla C., Patel V., Juluru R., et al. Quantification and prediction of skin pharmacokinetics of amoxicillin and cefuroxime. Biopharm Drug Dispos 2009, 30:281-293.
69. Marchand S., Chenel M., Lamarche I., et al. Pharmacokinetic modeling of free amoxicillin concentrations in rat muscle extracellular fluids determined by microdialysis. Antimicrob Agents Chemother 2005, 49:3702-3706.
70. Marchand S., Dahyot C., Lamarche I., et al. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob Agents Chemother 2005, 49:2356-2361.
71. Bidgood T., Papich M.G. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs. Am J Vet Res 2002, 63:1622-1628.
72. Matzi V., Lindenmann J., Porubsky C., et al. Extracellular concentrations of fosfomycin in lung tissue of septic patients. JAntimicrob Chemother 2010, 65:995-998.
73. Bidgood T.L., Papich M.G. Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. Am J Vet Res 2003, 64:1040-1046.
74. Bidgood T.L., Papich M.G. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. JVet Pharmacol Ther 2005, 28:329-341.